Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Prophylactic Administration of Glucocorticoids and Tacrolimus in AAV8-F8 Gene Therapy of Severe Haemophilia-a Achieved a Significant Long-Term Efficacy

Wei Liu, Xiaolei Pei, Bingqi Xu, Xinyue Dai, Feng Xue, Linging Chen, Yuhua Wang, Yunfei Chen, Xiaofan Liu, Rongfeng Fu, Wentian Wang, Ying Chi, Huiyuan Li, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 3583.

https://doi.org/10.1182/blood-2024-199915

Published: 2024

Journal Articles

Efficacy and Safety of an Engineered, Liver-Tropic Adeno-Associated Virus Vector Expressing Factor IX Padua Administered with Prophylactic Glucocorticoids in Patients with Hemophilia B: A Multi-Center, Single-Arm, Phase 3 Trial

Feng Xue, Mankai Ju, Tienan Zhu, ZePing Zhou, Jing Sun, Linhua Yang, Zhenyu Yan, Hu Zhou, Xin Du, Changcheng Zheng, Xia Wu, Xiao Xiao, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 3582.

https://doi.org/10.1182/blood-2024-204715

Published: 2024

Journal Articles

Recombinant ADAMTS13 Prophylaxis in Pediatric Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Crossover Study and the Phase 3b Continuation Study

Marie Scully, Claire Berger, Nathalie Biebuyck, Santiago Bonanad Boix, Claire Dossier, Wolf-Achim Hassenpflug, Karim Kentouche, Beverly Schaefer, Silvia Maria Trisolini, Runhui Wu, Juan Xiao, Feng Xue, Björn Mellgård, Munjal Patel, Parth Patwari, Linda T. Wang, Shan Xiao, Pinghai Zhang

Blood (2024) 144 (Supplement 1): 141.

https://doi.org/10.1182/blood-2024-199087

Published: 2024

Journal Articles

A Novel F12 Gene Pathogenic Mutation Identified in a Consanguineous Pedigree with Clustered Thrombotic and Pulmonary Disease

Xinmiao Qu, Xiaofan Liu, Rongfeng Fu, Yujiao Jia, Yuhua Wang, Feng Xue, Wei Liu, Yunfei Chen, Ting Sun, Mankai Ju, Huan Dong, Wenjing Gu, Xinyue Dai, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 5558.

https://doi.org/10.1182/blood-2024-202375

Published: 2024

Journal Articles

Demographics and Clinical Profile of Hemophilia Patients in China - Results from a Cross-Sectional, Community-Based Survey

Feng Xue, Chun Chang, Karina Chin Po Hsu, Jing Sun, Xinsheng Zhang, Shujie Wang, Jingsheng Wu, Rong Chen, Danni Shi, Felix Cao, Renchi Yang

Blood (2024) 144 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2024-207783

Published: 2024

Journal Articles

A Prospective Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Lusutrombopag in Chinese Adults with Persistent or Chronic Primary Immune Thrombocytopenia

Rongfeng Fu, Xiaofan Liu, Xinmiao Qu, Feng Xue, Wei Liu, Yunfei Chen, Ting Sun, Mankai Ju, Huan Dong, Wenjing Gu, Xinyue Dai, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 5438.

https://doi.org/10.1182/blood-2024-204932

Published: 2024

Journal Articles

A Single-Center Study of Patients with Isolated Acquired Clotting Factor Deficiency: Clinical Features, Treatments, and Prognosis

Dandan Yu, Feng Xue, Xiaofan Liu, Yunfei Chen, Rongfeng Fu, Ting Sun, Xinyue Dai, Mankai Ju, Huan Dong, Renchi Yang, Wei Liu, Lei Zhang

Blood (2023) 142 (Supplement 1): 3995.

https://doi.org/10.1182/blood-2023-173431

Published: 2023

Journal Articles

Single-Dose Rituximab Plus Glucocorticoid Versus Cyclophosphamide Plus Glucocorticoid in Patients with Newly Diagnosed Acquired Hemophilia a: A Multicenter, Open-Label, Randomized Clinical Trial

Wei Liu, Rongfu Zhou, Panjing Wang, Hu Zhou, Jie Bai, Xianghua Wang, Yueshen Ma, Zhen Song, Yunfei Chen, Xiaofan Liu, Rongfeng Fu, Ting Sun, Mankai Ju, Xinyue Dai, Huan Dong, Feng Xue, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 2628.

https://doi.org/10.1182/blood-2023-174587

Published: 2023

Journal Articles

CM313, a Novel Anti-CD38 Antibody, As a Potential Treatment for Primary Immune Thrombocytopenia: A Phase II Trial

Yunfei Chen, Xu Yanmei, Xuan Cao, Feng Xue, Ting Sun, Wei Liu, Mankai Ju, Rongfeng Fu, Xiaofan Liu, Xinyue Dai, Huiyuan Li, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 1206.

https://doi.org/10.1182/blood-2023-188664

Published: 2023

Journal Articles

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Blood (2023) 142 (Supplement 1): 2624.

https://doi.org/10.1182/blood-2023-174698

Published: 2023

Journal Articles

Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial

Blood (2023) 142 (Supplement 1): 687.

https://doi.org/10.1182/blood-2023-174591

Published: 2023

Journal Articles

Acquired Hemophilia a: A Single-Center Study of 165 Patients

Dandan Yu, Feng Xue, Xiaofan Liu, Yunfei Chen, Rongfeng Fu, Ting Sun, Xinyue Dai, Mankai Ju, Huan Dong, Renchi Yang, Wei Liu, Lei Zhang

Blood (2023) 142 (Supplement 1): 2623.

https://doi.org/10.1182/blood-2023-173407

Published: 2023

Journal Articles

Factor XI Deficiency in Chinese Patients: Results from a Nationwide Multicenter Retrospective Study

Xiyan Wang, Feng Xue, Wei Liu, Linging Chen, Lei Zhang, Renchi Yang

Blood (2023) 142 (Supplement 1): 5477.

https://doi.org/10.1182/blood-2023-184688

Published: 2023

Journal Articles

Pharmacokinetics, Safety and Preliminary Efficacy of Multiple Doses of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW117) in Previously Treated Adult and Adolescent Subjects with Severe Hemophilia a: Results from an Open-Label, Multicenter, Phase 2 Study

Feng Xue, Weizhi Chen, Shuxia Guo, Haiying Hua, Yu Cao, Xianqi Feng, Renchi Yang

Blood (2023) 142 (Supplement 1): 2615.

https://doi.org/10.1182/blood-2023-180649

Published: 2023

Journal Articles

AAV8 Gene Therapy for Hemophilia A Patients from China

Wei Liu, Feng Xue, Ting Sun, Bingqi Xu, Xiaolei Pei, Tenghui Yu, Fenglan Wu, Lijun Shen, Renchi Yang, Lei Zhang

Blood (2022) 140 (Supplement 1): 4925.

https://doi.org/10.1182/blood-2022-159363

Published: 2022

Journal Articles

Predictive Factors of Relapse for Primary Immune Thrombocytopenia in Adults: A Single-Center Retrospective Cohort Analysis

Xiyan Wang, Xiaofan Liu, Yueshen Ma, Jiao Wang, Rongfeng Fu, Yunfei Chen, Wei Liu, Ting Sun, Mankai Ju, Hui Yuan Li, Feng Xue, Changping Li, Zhen Song, Lei Zhang, Renchi Yang

Blood (2022) 140 (Supplement 1): 2214–2215.

https://doi.org/10.1182/blood-2022-164457

Published: 2022

Journal Articles

Pharmacokinetics, Efficacy and Safety Evaluation of FRSW107 in Previously Treated Hemophilia a Patients: A Multicentre, Open-Label, Non-Randomized Phase III Study

Blood (2022) 140 (Supplement 1): 8468–8469.

https://doi.org/10.1182/blood-2022-158760

Published: 2022

Journal Articles

Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

Wei Liu, Feng Xue, Rongfeng Fu, Bingjie Ding, Mengjuan Li, Ting Sun, Yunfei Chen, Liu Xiaofan, Mankai Ju, Xinyue Dai, Quanrui Wu, Zan Zhou, Xiaomin Wang, Jiaojiao Yu, Hu Zhou, Renchi Yang, Lei Zhang

Blood (2022) 140 (Supplement 1): 8474–8475.

https://doi.org/10.1182/blood-2022-159948

Published: 2022

Journal Articles

Factor VII Deficiency in China: The Genotype-Phenotype Analysis and Current Status of Management

Qu Cuiyun, Wei Liu, Lingling Chen, Lei Zhang, Feng Xue, Renchi Yang

Blood (2022) 140 (Supplement 1): 5629.

https://doi.org/10.1182/blood-2022-158661

Published: 2022

Journal Articles

Eltrombopag Combining Rituximab Versus Eltrombopag for Treatment of Adult Immune Thrombocytopenia: A Single Center, Retrospective Cohort Study

Xu Yanmei, Liu Xiaofan, Yunfei Chen, Feng Xue, Wei Liu, Rongfeng Fu, Ting Sun, Mankai Ju, Renchi Yang, Lei Zhang

Blood (2022) 140 (Supplement 1): 5565–5566.

https://doi.org/10.1182/blood-2022-168463

Published: 2022

NARROW

Prophylactic Administration of Glucocorticoids and Tacrolimus in AAV8-F8 Gene Therapy of Severe Haemophilia-a Achieved a Significant Long-Term Efficacy

Efficacy and Safety of an Engineered, Liver-Tropic Adeno-Associated Virus Vector Expressing Factor IX Padua Administered with Prophylactic Glucocorticoids in Patients with Hemophilia B: A Multi-Center, Single-Arm, Phase 3 Trial

Recombinant ADAMTS13 Prophylaxis in Pediatric Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Crossover Study and the Phase 3b Continuation Study

A Novel F12 Gene Pathogenic Mutation Identified in a Consanguineous Pedigree with Clustered Thrombotic and Pulmonary Disease

Demographics and Clinical Profile of Hemophilia Patients in China - Results from a Cross-Sectional, Community-Based Survey

A Prospective Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Lusutrombopag in Chinese Adults with Persistent or Chronic Primary Immune Thrombocytopenia

A Single-Center Study of Patients with Isolated Acquired Clotting Factor Deficiency: Clinical Features, Treatments, and Prognosis

Single-Dose Rituximab Plus Glucocorticoid Versus Cyclophosphamide Plus Glucocorticoid in Patients with Newly Diagnosed Acquired Hemophilia a: A Multicenter, Open-Label, Randomized Clinical Trial

CM313, a Novel Anti-CD38 Antibody, As a Potential Treatment for Primary Immune Thrombocytopenia: A Phase II Trial

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial

Acquired Hemophilia a: A Single-Center Study of 165 Patients

Factor XI Deficiency in Chinese Patients: Results from a Nationwide Multicenter Retrospective Study

Pharmacokinetics, Safety and Preliminary Efficacy of Multiple Doses of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW117) in Previously Treated Adult and Adolescent Subjects with Severe Hemophilia a: Results from an Open-Label, Multicenter, Phase 2 Study

AAV8 Gene Therapy for Hemophilia A Patients from China

Predictive Factors of Relapse for Primary Immune Thrombocytopenia in Adults: A Single-Center Retrospective Cohort Analysis

Pharmacokinetics, Efficacy and Safety Evaluation of FRSW107 in Previously Treated Hemophilia a Patients: A Multicentre, Open-Label, Non-Randomized Phase III Study

Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

Factor VII Deficiency in China: The Genotype-Phenotype Analysis and Current Status of Management

Eltrombopag Combining Rituximab Versus Eltrombopag for Treatment of Adult Immune Thrombocytopenia: A Single Center, Retrospective Cohort Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only